Multiple sclerosis (MS) is a condition that disrupts the information pathways that connect your brain and your body. From time to time, the symptoms of MS can unexpectedly worsen. When symptoms ...

Promising tolerability and efficacy results from dose-escalation in an ongoing phase Ib/II study of mosunetuzumab (M) with polatuzumab vedotin (Pola) in patients (pts) with relapsed/refractory (R/R) B ...

AlloHeme test accurately predicts relapse post-allo-HSCT in AML and MDS, with a median lead time of 36 days. The ACROBAT study involved 287 patients, showing significant predictive value of increased ...

In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA sequencing-based detection of residual disease between three and 12 months ...

Interleukin-23 inhibitors, prior treatment history, and Psoriasis Area and Severity Index scores may be predictive of time to disease relapse among patients with psoriasis who achieved clinical ...

Recovery from an eating disorder is typically a long process. Many people may even relapse during this time. Relapse is often due to stressful situations. Anorexia nervosa describes an eating disorder ...

Molecular profiling and prognosis of spindle cell/sclerosing rhabdomyosarcoma: A report from the Chinese PPOG trial. A phase Ib/II trial of radiotherapy combined with doxorubicin and PD-1 antibody for ...

Please provide your email address to receive an email when new articles are posted on . Patients who abruptly discontinued tocilizumab had significantly shorter time to relapse than those who tapered.

Sportschosun reporter Jang Jong-ho] Depression and bipolar disorder often relapse even after responding well to medication, making relapse prevention a key ...